Rhinomed launches fully underwritten rights issue
Rhinomed today announces a fully underwritten non-renounceable rights issue of fully paid ordinary shares, to raise approximately A$3.54 million. The funds raised will be used to drive growth in Rhinomed’s major markets; support the Company’s leading products, including the Mute range of products (Nasal Dilator, Mouth Tape, Turbine Nasal Dilator) and the Rhinoswab range of … Read more